The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibiotic Resistance Market Research Report 2025
Synopsis
Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
The global Antibiotic Resistance market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antibiotic Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Resistance.
Report Scope
The Antibiotic Resistance market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibiotic Resistance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibiotic Resistance manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
Segment by Type
By Disease
By Pathogen
Segment by Application
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibiotic Resistance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibiotic Resistance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
The global Antibiotic Resistance market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antibiotic Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Resistance.
Report Scope
The Antibiotic Resistance market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibiotic Resistance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibiotic Resistance manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
Segment by Type
By Disease
By Pathogen
Segment by Application
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibiotic Resistance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibiotic Resistance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antibiotic Resistance Market Overview
1.1 Product Overview and Scope of Antibiotic Resistance
1.2 Antibiotic Resistance Segment By Disease
1.2.1 Global Antibiotic Resistance Market Value Comparison By Disease (2024-2030)
1.2.2 By Disease
1.2.3 By Pathogen
1.3 Antibiotic Resistance Segment by Application
1.3.1 Global Antibiotic Resistance Market Value by Application: (2024-2030)
1.3.2 Oxazolidinones
1.3.3 Lipoglycopeptides
1.3.4 Tetracyclines
1.3.5 Cephalosporins
1.3.6 Combination therapies
1.3.7 Other
1.4 Global Antibiotic Resistance Market Size Estimates and Forecasts
1.4.1 Global Antibiotic Resistance Revenue 2019-2030
1.4.2 Global Antibiotic Resistance Sales 2019-2030
1.4.3 Global Antibiotic Resistance Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antibiotic Resistance Market Competition by Manufacturers
2.1 Global Antibiotic Resistance Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antibiotic Resistance Average Price by Manufacturers (2019-2024)
2.4 Global Antibiotic Resistance Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibiotic Resistance, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibiotic Resistance, Product Type & Application
2.7 Antibiotic Resistance Market Competitive Situation and Trends
2.7.1 Antibiotic Resistance Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antibiotic Resistance Players Market Share by Revenue
2.7.3 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibiotic Resistance Retrospective Market Scenario by Region
3.1 Global Antibiotic Resistance Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antibiotic Resistance Global Antibiotic Resistance Sales by Region: 2019-2030
3.2.1 Global Antibiotic Resistance Sales by Region: 2019-2024
3.2.2 Global Antibiotic Resistance Sales by Region: 2025-2030
3.3 Global Antibiotic Resistance Global Antibiotic Resistance Revenue by Region: 2019-2030
3.3.1 Global Antibiotic Resistance Revenue by Region: 2019-2024
3.3.2 Global Antibiotic Resistance Revenue by Region: 2025-2030
3.4 North America Antibiotic Resistance Market Facts & Figures by Country
3.4.1 North America Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antibiotic Resistance Sales by Country (2019-2030)
3.4.3 North America Antibiotic Resistance Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibiotic Resistance Market Facts & Figures by Country
3.5.1 Europe Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antibiotic Resistance Sales by Country (2019-2030)
3.5.3 Europe Antibiotic Resistance Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibiotic Resistance Market Facts & Figures by Country
3.6.1 Asia Pacific Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antibiotic Resistance Sales by Country (2019-2030)
3.6.3 Asia Pacific Antibiotic Resistance Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antibiotic Resistance Market Facts & Figures by Country
3.7.1 Latin America Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antibiotic Resistance Sales by Country (2019-2030)
3.7.3 Latin America Antibiotic Resistance Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibiotic Resistance Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antibiotic Resistance Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antibiotic Resistance Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antibiotic Resistance Sales by Type (2019-2030)
4.1.1 Global Antibiotic Resistance Sales by Type (2019-2024)
4.1.2 Global Antibiotic Resistance Sales by Type (2025-2030)
4.1.3 Global Antibiotic Resistance Sales Market Share by Type (2019-2030)
4.2 Global Antibiotic Resistance Revenue by Type (2019-2030)
4.2.1 Global Antibiotic Resistance Revenue by Type (2019-2024)
4.2.2 Global Antibiotic Resistance Revenue by Type (2025-2030)
4.2.3 Global Antibiotic Resistance Revenue Market Share by Type (2019-2030)
4.3 Global Antibiotic Resistance Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antibiotic Resistance Sales by Application (2019-2030)
5.1.1 Global Antibiotic Resistance Sales by Application (2019-2024)
5.1.2 Global Antibiotic Resistance Sales by Application (2025-2030)
5.1.3 Global Antibiotic Resistance Sales Market Share by Application (2019-2030)
5.2 Global Antibiotic Resistance Revenue by Application (2019-2030)
5.2.1 Global Antibiotic Resistance Revenue by Application (2019-2024)
5.2.2 Global Antibiotic Resistance Revenue by Application (2025-2030)
5.2.3 Global Antibiotic Resistance Revenue Market Share by Application (2019-2030)
5.3 Global Antibiotic Resistance Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Antibiotic Resistance Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 AmpliPhi Biosciences
6.2.1 AmpliPhi Biosciences Corporation Information
6.2.2 AmpliPhi Biosciences Description and Business Overview
6.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AmpliPhi Biosciences Antibiotic Resistance Product Portfolio
6.2.5 AmpliPhi Biosciences Recent Developments/Updates
6.3 BioVersys GmbH
6.3.1 BioVersys GmbH Corporation Information
6.3.2 BioVersys GmbH Description and Business Overview
6.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BioVersys GmbH Antibiotic Resistance Product Portfolio
6.3.5 BioVersys GmbH Recent Developments/Updates
6.4 Macrolide Pharmaceuticals
6.4.1 Macrolide Pharmaceuticals Corporation Information
6.4.2 Macrolide Pharmaceuticals Description and Business Overview
6.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Portfolio
6.4.5 Macrolide Pharmaceuticals Recent Developments/Updates
6.5 Melinta Therapeutics
6.5.1 Melinta Therapeutics Corporation Information
6.5.2 Melinta Therapeutics Description and Business Overview
6.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Melinta Therapeutics Antibiotic Resistance Product Portfolio
6.5.5 Melinta Therapeutics Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck Antibiotic Resistance Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Nabriva Therapeutics
6.6.1 Nabriva Therapeutics Corporation Information
6.6.2 Nabriva Therapeutics Description and Business Overview
6.6.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nabriva Therapeutics Antibiotic Resistance Product Portfolio
6.7.5 Nabriva Therapeutics Recent Developments/Updates
6.8 Nemesis Bioscience
6.8.1 Nemesis Bioscience Corporation Information
6.8.2 Nemesis Bioscience Description and Business Overview
6.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nemesis Bioscience Antibiotic Resistance Product Portfolio
6.8.5 Nemesis Bioscience Recent Developments/Updates
6.9 Phage Technologies S.A
6.9.1 Phage Technologies S.A Corporation Information
6.9.2 Phage Technologies S.A Description and Business Overview
6.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Phage Technologies S.A Antibiotic Resistance Product Portfolio
6.9.5 Phage Technologies S.A Recent Developments/Updates
6.10 Tetraphase Pharmaceuticals
6.10.1 Tetraphase Pharmaceuticals Corporation Information
6.10.2 Tetraphase Pharmaceuticals Description and Business Overview
6.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Portfolio
6.10.5 Tetraphase Pharmaceuticals Recent Developments/Updates
6.11 The Medicines Company
6.11.1 The Medicines Company Corporation Information
6.11.2 The Medicines Company Antibiotic Resistance Description and Business Overview
6.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.11.4 The Medicines Company Antibiotic Resistance Product Portfolio
6.11.5 The Medicines Company Recent Developments/Updates
6.12 TPfizer
6.12.1 TPfizer Corporation Information
6.12.2 TPfizer Antibiotic Resistance Description and Business Overview
6.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.12.4 TPfizer Antibiotic Resistance Product Portfolio
6.12.5 TPfizer Recent Developments/Updates
6.13 Westway Health
6.13.1 Westway Health Corporation Information
6.13.2 Westway Health Antibiotic Resistance Description and Business Overview
6.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Westway Health Antibiotic Resistance Product Portfolio
6.13.5 Westway Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibiotic Resistance Industry Chain Analysis
7.2 Antibiotic Resistance Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibiotic Resistance Production Mode & Process
7.4 Antibiotic Resistance Sales and Marketing
7.4.1 Antibiotic Resistance Sales Channels
7.4.2 Antibiotic Resistance Distributors
7.5 Antibiotic Resistance Customers
8 Antibiotic Resistance Market Dynamics
8.1 Antibiotic Resistance Industry Trends
8.2 Antibiotic Resistance Market Drivers
8.3 Antibiotic Resistance Market Challenges
8.4 Antibiotic Resistance Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
